TORONTO—Pauline Osena knows how crucial it is to have EpiPens close at hand for her two young sons, who are at risk of life-threatening anaphylaxis because of multiple food allergies.
So it’s no surprise that the latest short supply of the emergency rescue medication—an auto-injectable device that delivers a shot of symptom-relieving epinephrine—has her worried.